Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis)
Phase 4
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: NISE
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2016-10-04
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 202
- Registration Number
- NCT02922712
Amtolmetin Gaucil in Knee Osteoarthritis
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: NISELAT
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 220
- Registration Number
- NCT02865161
A Study to Assess the Efficacy, Safety and Tolerability of DFD-04
Phase 2
Completed
- Conditions
- Rosacea
- Interventions
- Drug: DFD-04 OintmentOther: Placebo Ointment
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 61
- Registration Number
- NCT02828241
- Locations
- 🇩🇪
Site 201, Berlin, Germany
🇩🇪Site 208, Berlin, Germany
🇩🇪Site 202, Bochum, Germany
Levofloxacin in Bacterial Rhinosinussitis
Completed
- Conditions
- Rhinosinusitis
- Interventions
- Drug: Amoxicillin-Potassium Clavulanate Combination
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2016-03-18
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 100
- Registration Number
- NCT02712502
Non Interventional Study of Levofloxacin in Chronic Prostatitis
Completed
- Conditions
- Chronic Prostatitis
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 500
- Registration Number
- NCT02711943
Ketorol Gel in Gonarthrosis and Low Back Pain
Phase 4
Completed
- Conditions
- GonarthrosisLow Back Pain
- Interventions
- First Posted Date
- 2015-12-23
- Last Posted Date
- 2017-03-13
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 240
- Registration Number
- NCT02638831
Pilot Study of DFN-11 Injection in Medication Overuse Headache
Phase 2
Terminated
- Conditions
- Medication Overuse Headache
- Interventions
- Drug: DFN-11 Injection
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 27
- Registration Number
- NCT02583425
- Locations
- 🇺🇸
Clinvest, Springfield, Missouri, United States
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
- First Posted Date
- 2015-10-09
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 250
- Registration Number
- NCT02572986
- Locations
- 🇺🇸
Omni Dermatology, Phoenix, Arizona, United States
🇺🇸Sun Rise Clinical Research, Inc, Bell Gardens, California, United States
🇺🇸Havana Research Institute, Pasadena, California, United States
Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine
- First Posted Date
- 2015-10-08
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 24
- Registration Number
- NCT02571049
- Locations
- 🇺🇸
Clinvest, Springfield, Missouri, United States
DFN-11 Injection in Episodic Migraine With or Without Aura
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 268
- Registration Number
- NCT02569853
- Locations
- 🇺🇸
Dr. Reddy's Investigational Site #18, Santa Monica, California, United States
🇺🇸Dr. Reddy's Investigational Site #24, Jacksonville, Florida, United States
🇺🇸Dr. Reddy's Investigational Site #23, Maitland, Florida, United States